Literature DB >> 22610008

Treatment of necrotizing pancreatitis.

Sandra van Brunschot1, Olaf J Bakker, Marc G Besselink, Thomas L Bollen, Paul Fockens, Hein G Gooszen, Hjalmar C van Santvoort.   

Abstract

Acute pancreatitis is a common and potentially lethal disease. It is associated with significant morbidity and consumes enormous health care resources. Over the last 2 decades, the treatment of acute pancreatitis has undergone fundamental changes based on new conceptual insights and evidence from clinical studies. The majority of patients with necrotizing pancreatitis have sterile necrosis, which can be successfully treated conservatively. Emphasis of conservative treatment is on supportive measures and prevention of infection of necrosis and other complications. Patients with infected necrosis generally need to undergo an intervention, which has shifted from primary open necrosectomy in an early disease stage to a step-up approach, starting with catheter drainage if needed, followed by minimally invasive surgical or endoscopic necrosectomy once peripancreatic collections have sufficiently demarcated. This review provides an overview of current standards for conservative and invasive treatment of necrotizing pancreatitis.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22610008     DOI: 10.1016/j.cgh.2012.05.005

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  19 in total

1.  Surgery for Acute Pancreatitis.

Authors:  Suresh Navadgi; Sanjay Pandanaboyana; John A Windsor
Journal:  Indian J Surg       Date:  2015-10-13       Impact factor: 0.656

Review 2.  The role of endoscopy in the management of pancreatic necrosis.

Authors:  Aaron Lewis; Brett Partridge; Oleh Haluszka
Journal:  Curr Gastroenterol Rep       Date:  2014-09

Review 3.  Endoscopic ultrasound in the diagnosis and treatment of pancreatic disease.

Authors:  Christopher W Teshima; Gurpal S Sandha
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  Factors impacting treatment outcomes in the endoscopic management of walled-off pancreatic necrosis.

Authors:  Ji Young Bang; C Mel Wilcox; Jessica Trevino; Jayapal Ramesh; Shajan Peter; Muhammad Hasan; Robert H Hawes; Shyam Varadarajulu
Journal:  J Gastroenterol Hepatol       Date:  2013-11       Impact factor: 4.029

5.  Endoscopic Management of Acute Biliopancreatic Disorders.

Authors:  Ryan M Juza; Eric M Pauli
Journal:  J Gastrointest Surg       Date:  2019-02-28       Impact factor: 3.452

6.  Percutaneous Endoscopic Necrosectomy of Complex Walled-Off Lateral Necrosis of the Pancreas with the Aid of Laparoscopic Babcock Forceps: A Case Report of an Endoscopic and Radiologic Team Approach.

Authors:  Andrew K Nguyen; Andrew J Song; Tanya Swopes; Albert Ko; Brian S Lim
Journal:  Perm J       Date:  2019-06-21

7.  Acute pancreatitis: too many classifications-what is a clinician or researcher to do?

Authors:  Dhiraj Yadav
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-30       Impact factor: 11.382

Review 8.  Timing of catheter drainage in infected necrotizing pancreatitis.

Authors:  Janneke van Grinsven; Hjalmar C van Santvoort; Marja A Boermeester; Cornelis H Dejong; Casper H van Eijck; Paul Fockens; Marc G Besselink
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-03-09       Impact factor: 46.802

9.  Retrospective analysis of clinical problems concerning acute pancreatitis in one treatment center.

Authors:  Dorota Kozieł; Monika Kozłowska; Jan Deneka; Jarosław Matykiewicz; Stanisław Głuszek
Journal:  Prz Gastroenterol       Date:  2013-10-28

10.  Pharmacokinetic and pharmacodynamic comparison of chinese herbal ointment liu-he-dan and micron liu-he-dan ointment in rats with acute pancreatitis.

Authors:  Shi-Feng Zhu; Wei-Wei Chen; Jin Xiang; Xian-Lin Zhao; Mei-Hua Wan; Qin Yu; Mao-Zhi Liang; Wen-Fu Tang
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.